Concepedia

Pavla Henklová

PH

Statistics

Publications

2

Citations

143

H-Index

2

Active since

2007

Affiliations

Inserm(Current)

Charles University

Université de Montpellier

Palacký University Olomouc

Pavla Henklová is an author at Inserm specializing in jnk signaling pathway, hepatic pathophysiology, and jnk pathway activation.

Publications per year

2007–2008

2

Publications

2

JNK inhibitor SP600125 is a partial agonist of human aryl hydrocarbon receptor and induces CYP1A1 and CYP1A2 genes in primary human hepatocytes

Zdeněk Dvořák, Radim Vrzal, Pavla Henklová et al. · Biochemical Pharmacology · 2007 · 76 citations

, , +16

SB203580, a pharmacological inhibitor of p38 MAP kinase transduction pathway activates ERK and JNK MAP kinases in primary cultures of human hepatocytes

Pavla Henklová, Radim Vrzal, Barbora Papoušková et al. · European Journal of Pharmacology · 2008 · 67 citations

, , +13

1–2 of 2